"The Emily Couric Clinical Cancer Center in Charlottesville, VA offers convenient access to a full range of state-of-the-art cancer treatments, all in a warm and inviting space."

During the past decade, University of Virginia Cancer Center conducted 174 clinical trials. In the 10-year time frame, 174 clinical trials started and 131 clinical trials were completed, i.e. on average, 75.3% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 72 clinical trials were completed. i.e. 118% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Virginia Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 117 trials, followed by "Children's Oncology Group" with 63 trials sponsored, "Gynecologic Oncology Group" with 46 trials sponsored, "Radiation Therapy Oncology Group" with 42 trials sponsored and "Alliance for Clinical Trials in Oncology" with 42 trials sponsored. Other sponsors include 148 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Virginia Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 260 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "SWOG Cancer Research Network" with 11 trials as a collaborator, "North Central Cancer Treatment Group" with 10 trials as a collaborator and "Cancer and Leukemia Group B" with 8 trials as a collaborator. Other collaborators include 89 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "University of Virginia Cancer Center" are "Ovarian Cancer" (23 trials), "Sarcoma" (19 trials), "Lung Cancer" (18 trials), "Breast Cancer" (17 trials) and "Leukemia" (15 trials). Many other conditions were trialed in "University of Virginia Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Virginia Cancer Center" are "Drug" (340 trials), "Biological" (157 trials), "Other" (153 trials), "Procedure" (124 trials) and "Radiation" (113 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (95 trials), "radiation therapy" (49 trials), "Quality-of-Life Assessment" (48 trials), "Carboplatin" (35 trials) and "Questionnaire Administration" (34 trials). Other intervention names were less common.

The vast majority of trials in "University of Virginia Cancer Center" are 317 trials for "All" genders, 111 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "University of Virginia Cancer Center". undefined are not yet recruiting, 60 are recruiting, 117 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 207 completed trials in University of Virginia Cancer Center, 5 suspended trials, and 34 terminated clinical trials to date.

Out of the total trials that were conducted in University of Virginia Cancer Center, 74 "Phase 1" clinical trials were conducted, 208 "Phase 2" clinical trials and 177 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".